All In Biotech

Drug Trial Radar · NCT02135315

Intensive Arterial Pressure Control in Acute Coronary Syndrome

One-year Outcome of Intensive Versus Standard Blood Pressure Treatment in Non-ST Elevation Acute Coronary Syndrome: A Randomised Controlled Trial

Last checked: Nov 19, 2026Latest source record: Aug 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,500

Actual

Start

Mar 2014

Primary completion

Dec 31, 2020

Study completion Dec 31, 2020

Sponsor

Lead sponsor
University of MonastirAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Emergency NGO Onlus
First posted
May 9, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 30 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The intensive arterial pressure control in acute coronary syndrome (ACS) during the first 24 hours can improve the prognosis in the short and long term. the study compare two treatment strategies (standard and intensive treatment) to assess their efficacy and safety in the treatment of acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome

Interventions

  • Isosorbide DinitrateDrug

    administration of continuous intravenous isosorbide dinitrate to obtain a SBP between 110 and 120 mmHg. After 2 hours from the start of treatment and if the blood pressure goal is not achieved, labetalol is used

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. mortalityTime frame: 12 months
  2. major cardiovascular events (MACE)Time frame: 12months
  3. combined mortality and MACE rateTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • university of Monastir

    Monastir, Tunisia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.